Home > National Drug Code (NDC) > RECOMBIVAX HB

RECOMBIVAX HB - 0006-4995-41 - (Hepatitis B Vaccine (Recombinant))

Alphabetical Index


Drug Information of RECOMBIVAX HB

Product NDC: 0006-4995
Proprietary Name: RECOMBIVAX HB
Non Proprietary Name: Hepatitis B Vaccine (Recombinant)
Active Ingredient(s): 10    ug/mL & nbsp;   Hepatitis B Vaccine (Recombinant)
Administration Route(s): INTRAMUSCULAR; SUBCUTANEOUS
Dosage Form(s): INJECTION, SUSPENSION
Coding System: National Drug Codes(NDC)

Labeler Information of RECOMBIVAX HB

Product NDC: 0006-4995
Labeler Name: Merck Sharp & Dohme Corp.
Product Type: VACCINE
FDA Application Number: BLA101066
Marketing Category: BLA
Start Marketing Date: 19860723

Package Information of RECOMBIVAX HB

Package NDC: 0006-4995-41
Package Description: 10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4995-41) > 1 mL in 1 VIAL, SINGLE-DOSE

NDC Information of RECOMBIVAX HB

NDC Code 0006-4995-41
Proprietary Name RECOMBIVAX HB
Package Description 10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4995-41) > 1 mL in 1 VIAL, SINGLE-DOSE
Product NDC 0006-4995
Product Type Name VACCINE
Non Proprietary Name Hepatitis B Vaccine (Recombinant)
Dosage Form Name INJECTION, SUSPENSION
Route Name INTRAMUSCULAR; SUBCUTANEOUS
Start Marketing Date 19860723
Marketing Category Name BLA
Labeler Name Merck Sharp & Dohme Corp.
Substance Name HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN
Strength Number 10
Strength Unit ug/mL
Pharmaceutical Classes Inactivated Hepatitis B Virus Vaccine [EPC],Actively Acquired Immunity [PE],Hepatitis B Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient]

Complete Information of RECOMBIVAX HB


General Information